Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
about
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patientsRational drug discovery design approaches for treating Parkinson's disease.Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.Anchorage of Au3+ into Modified Isoreticular Metal-Organic Framework-3 as a Heterogeneous Catalyst for the Synthesis of Propargylamines.From the Cover: Manganese and Rotenone-Induced Oxidative Stress Signatures Differ in iPSC-Derived Human Dopamine Neurons.Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects.
P2860
Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
@en
type
label
Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
@en
prefLabel
Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
@en
P2860
P1433
P1476
Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
@en
P2093
Paul L McCormack
P2860
P2888
P304
P356
10.1007/S40263-014-0206-Y
P577
2014-11-01T00:00:00Z